Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies of the reaction of 2-formylpyridine thiosemicarbazone and its iron and copper complexes with biological systems.

× No keyword cloud information.

10 in total

1. A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo.

Authors: Chad N Hancock; Luke H Stockwin; Bingnan Han; Raymond D Divelbiss; Jung Ho Jun; Sanjay V Malhotra; Melinda G Hollingshead; Dianne L Newton
Journal: Free Radic Biol Med Date: 2010-11-04 Impact factor: 7.376

2. Identification of compounds selectively killing multidrug-resistant cancer cells.

Authors: Dóra Türk; Matthew D Hall; Benjamin F Chu; Joseph A Ludwig; Henry M Fales; Michael M Gottesman; Gergely Szakács
Journal: Cancer Res Date: 2009-10-20 Impact factor: 12.701

3. Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.

Authors: Jill M Kolesar; Kamakshi Sachidanandam; William R Schelman; Jens Eickhoff; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal: Exp Ther Med Date: 2011-01 Impact factor: 2.447

4. Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.

Authors: Erika M Becker; David B Lovejoy; Judith M Greer; Ralph Watts; Des R Richardson
Journal: Br J Pharmacol Date: 2003-03 Impact factor: 8.739

Review 5. Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors: Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal: Trends Pharmacol Sci Date: 2009-09-15 Impact factor: 14.819

6. Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.

Authors: Matthew D Hall; Noeris K Salam; Jennifer L Hellawell; Henry M Fales; Caroline B Kensler; Joseph A Ludwig; Gergely Szakács; David E Hibbs; Michael M Gottesman
Journal: J Med Chem Date: 2009-05-28 Impact factor: 7.446

7. Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Authors: Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal: J Inorg Biochem Date: 2007-10-30 Impact factor: 4.155

8. Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.

Authors: Ana Popović-Bijelić; Christian R Kowol; Maria E S Lind; Jinghui Luo; Fahmi Himo; Eva A Enyedy; Vladimir B Arion; Astrid Gräslund
Journal: J Inorg Biochem Date: 2011-07-31 Impact factor: 4.155

9. Crystal structures of two hydrazinecarbo-thio-amide derivatives: (E)-N-ethyl-2-[(4-oxo-4H-chromen-3-yl)methyl-idene]hydrazinecarbo-thio-amide hemi-hydrate and (E)-2-[(4-chloro-2H-chromen-3-yl)methyl-idene]-N-phenyl-hydrazinecarbo-thio-amide.

Authors: Rajeswari Gangadharan; Jebiti Haribabu; Ramasamy Karvembu; K Sethusankar
Journal: Acta Crystallogr E Crystallogr Commun Date: 2015-02-21

10. New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.

Authors: Kateryna Ohui; Eleonora Afanasenko; Felix Bacher; Rachel Lim Xue Ting; Ayesha Zafar; Núria Blanco-Cabra; Eduard Torrents; Orsolya Dömötör; Nóra V May; Denisa Darvasiova; Éva A Enyedy; Ana Popović-Bijelić; Jóhannes Reynisson; Peter Rapta; Maria V Babak; Giorgia Pastorin; Vladimir B Arion
Journal: J Med Chem Date: 2018-12-18 Impact factor: 7.446

10 in total